Delivery Order SPE2DB20D2014-SPE2DB25FD20E
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,017.90 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count). This competitively awarded, firm fixed-price contract was finalized on September 23, 2025, with an ultimate completion date of September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 90 units, with a contract value of $1,559.63. The award, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, is structured as a firm fixed-price delivery order without set-aside designation. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30 count) with a contract ceiling value of $5,618.72. The award was issued on September 18, 2025, with an ultimate completion date of September 19, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count units) valued at $1,464.52 under a firm fixed-price contract. The delivery order, issued on September 26, 2025, requires completion by September 29, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded, reflecting the contractor's capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count) under a firm fixed-price contract valued at $8,062.31. The order was competitively awarded without set-aside designation and carries an ultimate completion date of August 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its Pennsylvania location as...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 30-tablet containers of Terbinafine HCL 250 mg with a ceiling value of $7,363.99 under a firm fixed-price delivery order contract. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, with no set-aside designation applied. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units, with a ceiling value of $2,964.57. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract is expected to be completed by September 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units, with a ceiling value of $3,320.50. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a typical transactional delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,056.95 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). The contract is a firm fixed price delivery order with an ultimate completion date of September 4, 2025, and was awarded on September 3, 2025. This non-set-aside award was competitively awarded, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The place of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $3,169.62 and an ultimate completion date of September 29, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. The order falls under...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD20EDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Terbinafine HCl 250 mg tablets in a 30-count configuration, with a contract ceiling value of $24,344.33. This is a firm fixed-price delivery order issued on September 29, 2025, with an ultimate completion date of September 30, 2025. The award carries no set-aside designation, indicating it was competitively awarded through open procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies military and veteran healthcare systems with a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities. The company's extensive portfolio of federal contract awards with DLA demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains, from common medications to specialized treatments. The DLA Troop Support Medical contract vehicle enables AmerisourceBergen Drug Corp to serve multiple federal customers, including the Defense Health Agency and U.S. Coast Guard, through a flexible contracting mechanism that supports military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.3k | 9/29/25 |